Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation. Simic D, Sang N. Exp Hematol 2019;72:36-46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Simic D, Sang N. Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation. Exp Hematol 2019;72:36-46.
PMID: 30611870